The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia https://www.nature.com/articles/s41420-024-01940-5
Discover the world at Altruu, The Discovery Engine
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia https://www.nature.com/articles/s41420-024-01940-5